Palantir Just Made a Power Move

The data giant inked a deal with a company that's already deployed nationwide. It is real-world security.

AMGEN Inc
NASDAQ:AMGN
$302.51

Financials

Curr Year EPS Estimate20.88
Next Quarter EPS Estimate5.31
Profit Margin17.49%
Operating Margin26.26
Return on Assets0.07
Return on Equity1.06
Revenue33.9B
Earnings Per Share10.97
Revenue Per Share63.49
Gross Profit23,569,999,872
Quarterly Revenue Growth0.09

General

NameAMGEN Inc
TickerAMGN
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees28,000

About AMGEN Inc

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividend

AMGEN Inc pays out a dividend of $9.65 per share, with a dividend yield of 3.19%.

AMGN's last dividend payment was made to shareholders on June 6, 2025.

They pay out 119.05% of their earnings out as a dividend.

Recent Dividends

Jun 6, 2025$2.38
Mar 7, 2025$2.38
Dec 9, 2024$2.25
Sep 6, 2024$2.25
Jun 7, 2024$2.25
Mar 7, 2024$2.25
Dec 8, 2023$2.13
Sep 8, 2023$2.13
Popular

Mary Kay Iconic Pink Cadillac Goes Electric: 'Driving Into A Transformative Future'

Seeing a Pink Cadillac on the road likely means the owner is a top Mary Kay salesperson. The newest pink Cadillacs are set to be electric vehicles.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

US health officials crack down on kratom-related products after complaints from supplement industry

WASHINGTON (AP) — U.S. health officials are warning Americans about the risks of an opioid-like ingredient increasingly added to energy drinks, gummies and supplements sold at gas stations and convenience stores, recommending a nationwide ban.

Why value investing has worked better outside the US

I recently interviewed investor and author Daniel Rasmussen for podcast, where he commented that “value hasn’t worked in the U.S., but it’s worked fine internationally.”

Altucher: It Looks Like My Trump Prediction Is Coming True - Ad

Trump's Great Gain has begun - and it could be the biggest crypto shift in U.S. history. With states like New Hampshire launching crypto reserves, everyday Americans could turn $900 into $108,000. But timing is critical.

Wisconsin man pleads guilty to smuggling lab equipment to Russian companies

MADISON, Wis. (AP) — A Wisconsin man pleaded guilty Tuesday to smuggling lab equipment to Russian companies in violation of trade sanctions the United States imposed after Russia invaded Ukraine.

The Most Hated Stock on Wall Street Is Hiding a Lucrative Opportunity - Ad

In 2010, the "Flash Crash" erased $1T in 36 minutes. Now, legendary trader Larry Benedict says the same force is hitting Tesla - triggering $25B-$100B swings before snapping back. He calls it the "Tesla Glitch" and reveals how to profit from it without buying or shorting a share.

Palo Alto Networks buying CyberArk in cash-and-stock deal valued at about $25 billion

Cybersecurity company Palo Alto Networks is buying CyberArk in a cash-and-stock deal valued at approximately $25 billion.

Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD

Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.

Brace Yourself for Jeff Bezos' "Amazon Helios" - Ad

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend -- twice featured on 60 Minutes -- predicts that "Amazon Helios" will be bigger than all of those... COMBINED.

Independent Voters' Approval Rating Of Donald Trump Plummets, Latest Poll Indicates

President Donald Trump's approval rating has seen a notable dip among independent voters, as indicated by a new Gallup survey.

FOMC Meeting Preview: Will Jerome Powell Accelerate The Bitcoin, Ethereum, XRP Bull Run?

Bitcoin (CRYPTO: BTC) and other cryptocurrencies continue to trade sideways ahead of Wednesday’s Federal Open Market Committee meeting, though pundits expect volatility to pick up soon.

Our No.1 AI Stock Has Nothing to Do With Tech - Ad

Nvidia CEO Jensen Huang recently said AI requires "100 times more" power. We believe that means the best way to invest in AI right now has nothing to do with technology ... And everything to do with energy. One stock appears to be perfectly positioned...

FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers

Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.

Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks

HC Wainwright initiates Ultragenyx at Buy with $80 target, citing strong rare disease pipeline and late-stage data expected by year-end.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'

President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.

Public Opinion Divided Over Donald Trump's Tax-And-Spending Law, New Poll Reveals

According to a recent poll, a significant skepticism among Americans towards President Trump's tax-and-spending law.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Trump-Xi Meeting On Horizon As US-China Hold Marathon 5-Hour Trade Talks In Stockholm

Officials from US and China met in Stockholm to extend trade truce, resolve economic disputes. Talks continue, Trump wants China to open economy.

FEMA Commits $608 Million To Support Trump's Migrant Detention Expansion

FEMA to distribute $608 million for immigrant detention centers, part of Donald Trump's immigration strategy.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the August 1st funding window closes.

Russia's Aeroflot cancels dozens of flights after cyberattack causes IT outage

Russian state-owned flagship carrier Aeroflot suffered a mass IT outage Monday following a cyberattack, Russia’s prosecutor’s office said, forcing the airline to cancel more than 100 flights and delay others.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Palantir Just Made a Power Move - Ad

The data giant inked a deal with a company that's already deployed nationwide. It is real-world security.

KLA Stock Rises 3.6% After Key Trading Signal

A significant trading signal occurred for KLA stock as it demonstrated a power inflow at $903.80, after which KLAC rose up to 3.6%.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

The beauty industry loves argan oil. But demand, and drought, are straining Morocco and its trees

SMIMOU, Morocco (AP) — Argan oil runs through your fingers like liquid gold — hydrating, luscious, and restorative. Prized worldwide as a miracle cosmetic, it’s more than that in Morocco. It’s a lifeline for rural women and a byproduct of a forest slowly buckling under the weight of growing demand.

Altucher: It Looks Like My Trump Prediction Is Coming True - Ad

Trump's Great Gain has begun - and it could be the biggest crypto shift in U.S. history. With states like New Hampshire launching crypto reserves, everyday Americans could turn $900 into $108,000. But timing is critical.

Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study

Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.

The Most Hated Stock on Wall Street Is Hiding a Lucrative Opportunity - Ad

In 2010, the "Flash Crash" erased $1T in 36 minutes. Now, legendary trader Larry Benedict says the same force is hitting Tesla - triggering $25B-$100B swings before snapping back. He calls it the "Tesla Glitch" and reveals how to profit from it without buying or shorting a share.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service